Anne Dorothée Schmitt

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

H. Ghesquières, Marion Chevrier, Mouna Laadhari et al. · Annals of Oncology · 2019 · 237 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Alterations in Rat Brain Proteins after Desflurane Anesthesia

Carsten Fütterer, Martin H. Maurer, Anne Dorothée Schmitt et al. · Anesthesiology · 2004 · 91 citations

Life Sciences, Biochemistry, Neuroscience +13

Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia

Kirsten Hattermann, Susanne Sebens, Ole Helm et al. · Oncology Reports · 2014 · 64 citations · Full text

Medicine, Immunology, Oncology +14

INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMAS

Franck Morschhauser, Gilles Salles, Pam McKay et al. · Hematological Oncology · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +13

Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial

Laurence Brugières, Nathalie Cozic, Roch Houot et al. · European Journal of Cancer · 2023 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16